Volume Alert - MDT 69.46 Medtronic Inc $MDT Hit a high

New Post Public Reply Private Reply Replies (0) Message Board
leahanne
Volume Alert - MDT 69.46 Medtronic Inc $MDT Hit a high today of 69.47 Closing the day 10:30 at 69.46 +0.96 +1.40% With a day low of 68.66 and a total volume of 1,765,755.

MDT Recent Posts: http://investorshangout.com/Medtronic-Inc-MDT-51763/

MDT Medtronic Inc Recent Headline News

Early Glance: Medical Devices companies
AP - 40 mins ago
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 10 a.m.:
ZMH: 110.70 (-0.17), JNJ: 108.92 (+0.17), MDT: 69.35 (+0.85), BAX: 72.07 (+0.74)

Global Insulin Delivery Devices Market Outlook 2018
M2 - Thu Nov 13, 4:59AM CST
Research and Markets (http://www.researchandmarkets.com/research/ttg7ws/global_insulin) has announced the addition of the "Global Insulin Delivery Devices Market Outlook 2018" report to their offering. In 2013, a total of 382 Million People had diabetes and by 2030 this number is expected to rise to 552 Million. This finding by the International Diabetes Federation (IDF) and similar results from studies done by organizations of repute such as WHO, CDC, NHS, etc., suggest that a huge patient population exists in the diabetes market. In 2013, health expenditure on diabetes accounted for around 10% of the total health expenditure globally. Of all the market segments that result from this multibillion dollar expenditure, insulin delivery devices represents one of the most rapidly expanding areas and is thus the key focus of this current study. In this latest research study Global Insulin Delivery Devices Market Outlook 2018, the analysts identified the market dynamics in various important regions to highlight the areas offering promising opportunities to companies for boosting their growth. Insulin delivery devices predominantly include Insulin Syringes, Insulin Pens (Disposable and Reusable), Insulin Pumps and Insulin Jet Injectors. Our study provides a comprehensive analysis of the delivery devices market, both at global and regional levels. This analysis includes the current market statistics, key drivers stimulating each segment's growth, and the future outlook of the segments. Key Topics Covered: 1. Analyst View 2. Research Methodology 3. Global Insulin Market Overview to 2018 4. Industry Trends and Drivers 5. Key Market Restraints 6. Global Insulin Delivery Devices Market Outlook to 2018 7. Insulin Delivery Devices: Current and Future Outlook to 2018 8. Emerging Devices 9. Key Players Companies Mentioned: - Abbott Laboratories - B. Braun Melsungen AG - Becton Dickinson - Eli Lilly - F. Hoffmann La Roche - Insulet Corporation - Johnson and Johnson - Medtronic - Novo Nordisk - Sanofi-Aventis - Ypsomed Holding AG For more information visit http://www.researchandmarkets.com/research/tt...al_insulin
JNJ: 108.92 (+0.17), ABT: 44.54 (+0.31), PODD: 46.39 (-0.01), NVO: 44.01 (-0.31), MDT: 69.35 (+0.85), LLY: 67.83 (+0.43)

Neurostimulation Devices Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Competitive Scenario And Forecasts, 2012 To 2020
M2 - Thu Nov 13, 2:52AM CST
Industry Insights
BSX: 13.42 (+0.01), MDT: 69.35 (+0.85), CYBX: 50.98 (+0.46)

Final Glance: Medical Devices companies
AP - Wed Nov 12, 5:02PM CST
NEW YORK (AP) — Shares of some top medical devices companies were mixed at the close of trading:
ZMH: 110.70 (-0.17), JNJ: 108.92 (+0.17), MDT: 69.35 (+0.85), BAX: 72.07 (+0.74)

Medtronic Adds to Endurant 'AAA' Stent Graft System
Thomson Reuters ONE - Wed Nov 12, 2:00PM CST
New Bifurcated Component Leverages Proven Design of Predicate Device and Expands Anatomical Customization Options for Endovascular Repair of Abdominal Aortic Aneurysms
MDT: 69.35 (+0.85)

Midday Glance: Medical Devices companies
AP - Wed Nov 12, 12:23PM CST
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 1 p.m.:
ZMH: 110.70 (-0.17), JNJ: 108.92 (+0.17), MDT: 69.35 (+0.85), BAX: 72.07 (+0.74)

Medtronic and St. Jude Medical Dominate the European Pain Management Device Market
PR Newswire - Wed Nov 12, 11:00AM CST
Decision Resources Group finds that the European pain management device market generates a majority of revenue from select products, such as spinal cord stimulation (SCS) and radiofrequency (RF) ablation devices. This results in key players like Medtronic and St. Jude Medical capturing significant share. Increasing recognition of the value of pain management devices over pharmaceuticals will, however, drive moderate market growth, leading to increased competition as manufacturers shift focus to the device market.
MDT: 69.35 (+0.85)

Global Orthopedic Implant Physician Preference Survey 2015 - Executive Summary
M2 - Wed Nov 12, 9:15AM CST
Research and Markets (http://www.researchandmarkets.com/research/wkgmtc/global_orthopedic) has announced the addition of the "Global Orthopedic Implant Physician Preference Survey 2015 (Executive Summary)" report to their offering. This survey asked physicians to choose the company or companies that provide knee repair products with which they are most satisfied. More than one-third of respondents who do knee repair surgeries included DePuy Synthes as one of their preferred companies. This was followed closely by other competitors such as MAKO Surgical, Smith & Nephew, Stryker and Zimmer. The survey also asked physicians to suggest what factor or factors would most likely trigger them to switch over to using a different knee repair product from that which they were currently most comfortable. While many surgeons suggested multiple factors, one that appeared most frequently was if another product was able to demonstrate better clinical efficacy in comparison to the current product in use. This trend was present from respondents across all geographical regions and clinical settings. Despite subtle differences in physician product preference across the various regions, the survey results suggest that DePuy Synthes is the most highly preferred supplier of knee repair products globally. Key Topics Covered: - Survey Background - Survey Respondent Profile - Knee Repair Products - Foot Digit Repair Products - Hip Repair Products - Hand Digit Repair Products - Spinal Surgery Products - Custom Implants Companies Mentioned - Aesculap - Alphatec Spine - Arthrex - BioPro - Biomet - DJO Surgical - DePuy Synthes - Exactech - Globus Medical - Integra LifeSciences - K2M - MAKO Surgical - Medtronic - NuVasive - Small Bone Innovations (SBi) - Smith & Nephew - Stryker - Wright Medical - Zimmer For more information visit http://www.researchandmarkets.com/research/wk...orthopedic
SNN: 33.68 (+0.15), MDT: 69.35 (+0.85), GMED: 23.04 (-0.12)

Global Orthopedic Implant Physician Preference Survey 2015
M2 - Wed Nov 12, 9:04AM CST
Research and Markets (http://www.researchandmarkets.com/research/9rfcq6/global_orthopedic) has announced the addition of the "Global Orthopedic Implant Physician Preference Survey 2015" report to their offering. This survey asked physicians to choose the company or companies that provide knee repair products with which they are most satisfied. More than one-third of respondents who do knee repair surgeries included DePuy Synthes as one of their preferred companies. This was followed closely by other competitors such as MAKO Surgical, Smith & Nephew, Stryker and Zimmer. The survey also asked physicians to suggest what factor or factors would most likely trigger them to switch over to using a different knee repair product from that which they were currently most comfortable. While many surgeons suggested multiple factors, one that appeared most frequently was if another product was able to demonstrate better clinical efficacy in comparison to the current product in use. This trend was present from respondents across all geographical regions and clinical settings. Despite subtle differences in physician product preference across the various regions, the survey results suggest that DePuy Synthes is the most highly preferred supplier of knee repair products globally. Survey includes: - Patient Volumes - Procedures Performed - Clinical Setting - Product prerference by manufacturer - Factors influencing produt change - Preferences by region, country and clinical setting Key Topics Covered: 1. Executive Summary 2. Research Methodology And Survey Coverage 3. Survey Respondent Profile 4. Osteoarthritis Treatment Preferences 5. Product Preference Overview 6. Knee Repair Products 7. Hip Repair Products 8. Hand Digit Repair Products 9. Foot Digit Repair Products 10. Cervical Interbody Products 11. Thoracolumbar Interbody Products 12. Custom Implants Companies Mentioned - Aesculap - Alphatec Spine - Arthrex - BioPro - Biomet - DJO Surgical - DePuy Synthes - Exactech - Globus Medical - Integra LifeSciences - K2M - MAKO Surgical - Medtronic - NuVasive - Small Bone Innovations (SBi) - Smith & Nephew - Stryker - Wright Medical - Zimmer For more information visit http://www.researchandmarkets.com/research/9r...orthopedic
SNN: 33.68 (+0.15), MDT: 69.35 (+0.85), GMED: 23.04 (-0.12)

Wall Street Breakfast: Global Banks Fined $3.4B In Forex Probe
Wall Street Breakfast - Seeking Alpha - Wed Nov 12, 5:30AM CST
Economy Japanese stocks scaled seven-year highs this morning on further speculation that Prime Minister Shinzo Abe will postpone a planned sales tax hike and call a general election for December. The Sankei newspaper reported that Abe would...
VRX: 131.78 (+0.69), MDT: 69.35 (+0.85), C: 53.28 (-0.14), WMT: 82.58 (+3.38), RBS: 11.75 (-0.07), UBS: 17.54 (+0.16), NOK: 8.25 (+0.20), YHOO: 50.70 (+0.10), PBR: 10.33 (-0.23), SPY: 204.18 (+0.22), SAP: 66.58 (+0.13), EBAY: 54.41 (+0.35), JPM: 60.36 (-0.20), BHP: 57.84 (-0.34), AAPL: 113.05 (+1.80), BCS: 14.45 (-0.13), FRM: 6.34 (-0.25), COV: 94.13 (+1.25), HSBC: 50.10 (-0.12), FRGI: 56.37 (-0.30), ZTS: 43.02 (+0.38), DLA: 10.45 (-0.10), QQQ: 103.08 (+0.62), AOL: 46.46 (+0.62), BABA: 116.46 (-1.74)

Medtronic submits concessions for $43B Covidien takeover
Seeking Alpha - at Seeking Alpha - Wed Nov 12, 3:53AM CST

MDT: 69.35 (+0.85), COV: 94.13 (+1.25)

Three Medtronic Infuse Personal Injury Cases Remanded to Circuit Court, Parker Waichman LLP Announces
PRWeb - Tue Nov 11, 2:30PM CST
Parker Waichman LLP, a national law firm that has long been dedicated to protecting the rights of victims who have been injured during medical procedures and by medical devices, comments on a Court ruling in which three lawsuit filed against Medtronic, Inc. will be remanded to the Circuit Court of the City of St. Louis for further proceedings. Parker Waichman LLP is collaborating on these cases with Neblett Beard & Arsneault and The Drakulich Firm.
MDT: 69.35 (+0.85)

DexCom Scales 52-Week High on Product Pipeline Strength - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 11, 1:10PM CST
Impressive third-quarter 2014 results, recent FDA approvals for its new products along with a robust product pipeline contribute to the growth trajectory of DexCom, Inc. (DXCM), creating good momentum for 2015 as well.
ABT: 44.54 (+0.31), JNJ: 108.92 (+0.17), DXCM: 54.04 (+0.03), MDT: 69.35 (+0.85)

Mid-Term Election Impacts On The Market Revisited
Bret Jensen - at Seeking Alpha - Tue Nov 11, 10:27AM CST

SPY: 204.19 (+0.23), QQQ: 103.08 (+0.62), MDT: 69.35 (+0.85), IEF: 104.82 (+0.11), DIA: 176.56 (+0.52), STJ: 65.62 (-0.06), IWM: 117.41 (-0.49), TLT: 118.76 (+0.13)

Medtronic (MDT) Breaks Through Resistance at $69.08
Comtex SmarTrend(R) - Tue Nov 11, 10:14AM CST
Shares of Medtronic (NYSE:MDT) opened today above their pivot of $68.38 and have already reached the first level of resistance at $69.08. Should the shares continue to rise, the resistance pivots of $69.44 and $70.50 will be of interest.
MDT: 69.36 (+0.86)

Actavis Says 'Let's Make A Deal'
Bill Gunderson - Seeking Alpha - Tue Nov 11, 8:42AM CST
I wrote about generic and specialty drug company Actavis plc (NYSE: ACT ) a while back detailing the rumored love triangle between them, Allergan (NYSE: AGN ), Valeant Pharmaceuticals (NYSE: VRX ), and Salix Pharmaceuticals (NASDAQ: SLXP ). On...
DRTX: 23.80 (-0.09), AGN: 196.60 (+0.09), ACT: 241.86 (+1.24), VRX: 131.78 (+0.69), MDT: 69.36 (+0.86), SLXP: 96.70 (+1.15), SNY: 46.52 (-0.04)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Midterm Voters Put Cost Relief Ahead of Washington Wars

Updated Category News Views 140

Gas pumps and medical bills have a way of humiliating every grand political slogan ever printed. Seven Letter Insight's latest post-election survey says confirmed 2026 midterm voters want the 120th Congress to deal with costs first, particularly gas prices, health care, restoring health care tax credits and energy bills. That is not a glamorous mandate. It is, however,...

Continue Reading
ModuleMD Takes Allergy EHR AI Beyond the Usual Hype Cycle

Updated Category News Views 203

Allergy Workflows Are Where This Has to Earn Its Keep Allergy clinics do not need another shiny dashboard clogging up a workstation. They need less typing, fewer handoffs, cleaner documentation, and fewer administrative chores slipping through the cracks while a packed day keeps moving. That is the practical lens for ModuleMD's ACAAI 2026 presentation in Phoenix: not...

Continue Reading
Fractional CIOs Bring Order to Growing Technology Chaos

Updated Category News Views 71

A company can outgrow its technology habits long before anyone notices the smoke. One day the owner is approving another software subscription, the office manager is chasing an internet provider, and the tech person is putting out password fires. None of that looks dramatic in isolation. Together, it is a business operating without a map. That is the useful point in the...

Continue Reading
Highmark’s 2026 Rebound Has a Few Asterisks Attached

Updated Category News Views 95

The Headline Needs a Pencil, Not a Highlighter A $1.9 billion net-income figure can look downright thunderous until you separate the cash-generating engine from the accounting cargo strapped to it. Highmark Health reported $26.5 billion in revenue and $741 million in operating income for the nine months ended Sept. 30, 2026. Those are materially better numbers than the...

Continue Reading
Employer Ghosting Is a Quiet Talent-Cost Problem Today

Updated Category News Views 126

Silence is cheap right up until a company needs talent again. Then the unanswered email, abandoned interview loop, or vanished promise of next steps comes back with a price tag—maybe not neatly labeled in a quarterly filing, but real all the same. LiveCareer’s April 14, 2026 survey of 1,008 employed U.S. adults lands on an uncomfortable point: candidates remember...

Continue Reading
Alibaba Lawsuit Deadline Puts Disclosure Risk in Focus

Updated Category News Views 180

A calendar deadline is doing more work than any earnings headline for Alibaba shareholders this week. A securities class action notice says investors who bought or acquired Alibaba Group Holding Limited securities between May 23, 2024 and November 11, 2026 may seek appointment as lead plaintiff by January 19, 2027. That is a procedural milestone, not a verdict, and...

Continue Reading
Persistent Dry Eye Symptoms Call for a Closer Look

Updated Category News Views 78

Eyes can turn into a stubborn little nuisance long before people realize something more complicated is going on. A bottle of artificial tears is easy to grab, cheap enough, and often perfectly sensible for a rough day of screens, wind, reading, or air conditioning. But Dr. Harlan Snyder’s point is the one worth sitting with: when dryness keeps barging back despite...

Continue Reading
Domino's Probe Puts Franchise Disclosure Under Lens

Updated Category News Views 139

A franchisee's shuttered stores can turn cheerful unit-growth talk into a nasty accounting of credibility, and that is the uncomfortable territory Domino's now occupies. Kahn Swick & Foti has opened an investigation into whether Domino's officers and directors breached fiduciary duties or violated state or federal law. That is not a finding of misconduct. It is a legal...

Continue Reading
ASA’s 2026 Grants Push Dermatology Into New Terrain

Updated Category News Views 116

Thirteen Small Bets With Serious Human Stakes Skin science rarely gets the splashy headlines, yet it touches a staggering number of people and carries some very stubborn unanswered questions. American Skin Association’s 2026 grant class puts 13 awards across skin cancer and dermatologic disease, with a noticeable willingness to follow newer clinical terrain rather than...

Continue Reading
QuidelOrtho Faces Fresh Scrutiny Over Savanna Claims

Updated Category News Views 172

A diagnostic launch can turn into a corporate migraine with frightening speed, and QuidelOrtho is staring at exactly that sort of mess. Kahn Swick & Foti said on November 20, 2026, that it has begun investigating whether QuidelOrtho officers or directors breached fiduciary duties or otherwise violated state or federal law. This is not a finding of wrongdoing. It is an...

Continue Reading

Top 5 Most Recently Viewed Articles

Bitcoin Faces Criticism While BlackRock Sees Financial Success

Updated Category News Views 167

Bitcoin Under Scrutiny In recent discussions, Peter Schiff has taken to social media to share his critical views on Bitcoin, branding it as a "fake asset." His assertion comes after Bitcoin's price retracement from its historic highs, indicating a significant downturn. Currently, Bitcoin is trading at around $81,000 after once peaking at $110,000. Schiff argues that the...

Continue Reading
Valneva Secures $32.8 Million Contract for IXIARO Vaccine Supply

Updated Category News Views 213

Valneva Expands IXIARO Vaccine Supply with New Contract Valneva SE, a leading specialized vaccine company, has officially announced a significant step forward in its partnership with the U.S. Department of Defense (DoD) by signing a new contract valued at a minimum of $32.8 million for the IXIARO vaccine. This substantial agreement marks another chapter in Valneva's...

Continue Reading
EFGH and Minerva Forge Strategic Partnership for Data Centres

Updated Category News Views 118

EFGH and Minerva Unite to Enhance Ghana's Digital Landscape In a landmark agreement, Embed Financial Group Holdings (EFGH) has joined forces with Minerva Data Limited, a prominent player in digital infrastructure, to create advanced data centres and strengthen the technology ecosystem in Ghana. This collaboration marks a significant step in addressing the growing demand...

Continue Reading
Landsea Homes Achieves Remarkable Growth in Q3 Results

Updated Category News Views 50

Strong Financial Performance in Q3 Landsea Homes Corporation (NASDAQ: LSEA) reported impressive financial results for the third quarter, demonstrating robust performance in the residential homebuilding sector. For the quarter, Landsea Homes achieved a net income of $11.1 million, translating to $0.30 per share. This marks a 29% increase in net income compared to the...

Continue Reading
Urban Logistics REIT: Key Disclosure Insights for Investors

Updated Category News Views 219

Understanding the Disclosure from Urban Logistics REIT In the realm of public trading, disclosures play a pivotal role in keeping investors informed about changes in significant stakes within companies. Recently, Urban Logistics REIT Plc, underlining its commitment to transparency, provided valuable insights through its disclosure concerning investor positions, managed by...

Continue Reading